Sees Q1 adjusted EBITDA $30M-$40M. the company said, “For the first fiscal quarter ending December 31, 2025, revenue is expected to be in the range of $110 million to $120 million, where no material fixed license revenue contracts are currently expected to be signed during the quarter and including a $49.5 million patent license payment. Gross margins are projected between 85% and 86%, and net (loss) income is projected to be in the range of $(2.4) million to $7.6 million. Adjusted EBITDA is expected to be in the range of $30 million to $40 million. The adjusted EBITDA guidance excludes amortization of acquired intangible assets, stock-based compensation, restructuring and other costs.”
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRNC:
- Cerence options imply 13.9% move in share price post-earnings
- Options Volatility and Implied Earnings Moves Today, November 19, 2025
- Options Volatility and Implied Earnings Moves This Week, November 17 – November 20, 2025
- CRNC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- The 3 Speech Recognition Underdogs Finding Their Voice: SOUN, EGHT, and CRNC